Back to Archived Journals » Comparative Effectiveness Research » Volume 7

Cost-effectiveness of sunitinib as second-line treatment for gastrointestinal stromal tumor in the People’s Republic of China

Total article views   HTML views PDF downloads Totals
11,215 Dovepress* 11,215+ 827 12,042
Totals 11,215 827 12,042
*Since 23 January 2017

View citations on Google Scholar